1100 WINTER STREET, WALTHAM, MA
Reports First Quarter 2026 Financial Results and Provides Business Updates
Annual Report to Security Holders
CFO Resignation - Matthew Gall Steps Down at Kalaris Therapeutics
Reports Full Year 2025 Financial Results and Provides Business Updates
Investor Presentation
Announces Oversubscribed $50.0 Million Private Placement
Reports Third Quarter 2025 Financial Results and Provides Business Updates
Q1
Q3
Q2
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
SEC Staff Correspondence
Correspondence
Submission Upload